이 에피소드에 관해
In this episode, we cover the man behind the largest biotechnology IPO in history, Steve Harr. Steve co-founded Sana biotechnology, a company that went public earlier this year (2021) and raised almost $600 million dollars in its IPO. Sana is changing the way diseases are cured. Their approach is based on repairing and controlling genes within cells, essentially engineering cells so that they are better equipped to fight off diseases. Prior to co-founding Sana, Steve served as an executive at Juno Therapeutics, a biotech company that was acquired for $11 billion in 2018, and worked as managing director at Morgan Stanley for over a decade. If you stick around for the whole episode, you'll get insight into the extreme highs and lows of Steve's career journey, you will hear what Steve would advise his younger self, and you will get a peek into how he thinks about leadership.
